Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVGR.L Regulatory News (AVGR)

  • There is currently no data for AVGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

21 Mar 2012 07:00

RNS Number : 7446Z
AvangardCo Investments Public Ltd
21 March 2012
 



March 21, 2012

 

 

AVANGARDCO INVESTMENTS PUBLIC LIMITED

FINANCIAL RESULTS FOR 2011

 

KYIV, UKRAINE - AVANGARDCO INVESTMENTS PUBLIC LIMITED (LSE: AVGR) (the «Company» or «AVANGARDCO IPL»), the largest producer of shell eggs and egg products in Ukraine and the second largest in the world, announces its financial results for the year to 31 December 2011.

 

Financial highlights

§ Revenue increased by 25.8% yoy to US$553.3 mln (2010: US$439.7 mln) driven by sales growth in shell eggs and egg products and the increase in egg prices;

§ EBITDA was up by 27% yoy and reached US$245.8 mln (2010: US$193.5 mln), with EBITDA margin of 44%;

§ Operating profit increased by 30% yoy to US$231.5 mln (2010: US$180.9 mln), with an operating profit margin of 41.8%

§ Net profit for the year grew by 6.2% yoy to US$196.3 mln (2010: US$184.8 mln), with profit margin of 35.5%;

§ Cash balance stood at US$230.6 mln at the end of 2011 (2010: US$183.1 mln).

 

Operational highlights

§ Total flock increased by 3.3% yoy to 25.1 mln (2010: 24.3 mln). In 2011 the number of laying hens increased by 9.6% yoy to 20.5 mln (2010: 18.7 mln);

§ Production of shell eggs increased by 34.7% to 5.955 bln (2010: 4.420 bln);

§ Sales of shell eggs to external clients increased by 25% yoy to 4.862 bln (2010: 3.888 bln);

§ The share of shell egg sales through modern retail chains (supermarkets) increased to 30% of total sales to external customers (2010: 16%);

§ The average selling price of eggs increased by 12.3% yoy and amounted to UAH 0.641/ US$0.082 (2010: UAH 0.573 / US$0.074);

§ The production of dry egg products increased by 19.6% yoy reaching 12.2 thou tonnes (2010: 10.2 thou tons), or 1.1 bln eggs in egg equivalent (2010: 0.8 bln eggs);

§ The Company exported approximately 1.1 bln shell eggs and dry egg products in egg equivalent;

§ The average sale price of dry egg products decreased by 1.9% yoy to US$8.05/kg (2010: US$8.21/kg);

§ Revenue from the export of shell eggs and egg products grew by 29.4% yoy to US$105.6 mln or 19% of total revenue. Key sales export destinations in 2011 were the Middle East (10.5%) and the Far East (8.3%);

§ In November 2011 the Company launched the renewed brand of packaged eggs "Kvochka" ("Mother Hen"), which combines high quality and affordability;

§ The Company launched the 1st stage of facilities for laying hens at its new egg production complex Avis.

 

 

1 Excl. VAT

2 Average exchange rate in 2011: 1 US$ = UAH 7.9677; 2010: 1 US$ = UAH 7.9353

3 Excl. VAT

4 Average exchange rate in 2011: 1 US$ = UAH 7.9677; 2010: 1 US$ = UAH 7.9353

 

 

Nataliya Vasylyuk, Chief Executive Officer of AVANGARDCO IPL, said: 

 

"I am pleased to report a strong performance by the Company in 2011 with significant growth in revenue, EBITDA and operating profit. This result was achieved on the back of the increase in shell egg production to almost 6 billion pieces and continued diversification of our sales channels, both domestically and for export. Our egg products production grew to 1.1 billion of eggs equivalent in the same period. This year we became the number one egg producer in Eurasia and the second largest company globally in terms of production volumes of shell eggs and egg products, an achievement unmatched by any other company from the former USSR. This success is testament to both our progress as a company, and also to Ukraine's agricultural potential."

 

Current trading and outlook

 

The Company expects further growth in sales due to high demand for shell eggs and egg products in Ukraine, as well as the active implementation of its export plans. Furthermore, levels of sales will be supported by an increase in the Company's poultry flock. The Company will continue to diversify its customer base in Ukraine, paying special attention to retail channel and development of additional brands. Due to record harvests in Ukraine in the fall of 2011, the Company was able to purchase grains at a very attractive price to use for feeding its flocks in the remainder of 2011 and the majority of 2012

 

Financial and Operational Review

 

US$ '000

2011

2010

Change yoy

Revenue

553,310

439,703

25.8%

Gross Profit

223,775

157,746

41.9%

Gross Profit Margin

40.4%

35.9%

/

EBITDA

245,834

193,539

27.0%

EBITDA Margin

44.4%

44.0%

/

Operating Profit

231,504

180,902

28.0%

Operating Margin

41.8%

41.1%

/

Net Profit

196,294

184,758

6.2%

Net Profit Margin

35.5%

42.0%

/

 

 

Operational Review

 

The Company's revenue increased by 25.8% year-on-year as a result of 25% growth in sales volumes of shell eggs and 10% growth in sales volumes of dry egg products, as well as an increase in shell egg prices of 12.3%. The Company's Shell Eggs segment accounted for 70% of the Company's total revenue in 2011. Revenue from sales of shell eggs to external clients was US$389.3 mln, a 38.9% increase over the previous year (2010: US$280.3 mln). This result was achieved due to a 35% growth year-on-year in the production of shell eggs from 4.42 bln to 5.96 bln shell eggs.

 

In 2011, the Company increased its total flock by 3.3% from 24.3 mln to 25.1 mln. The number of laying hens increased by 9.6% to 20.5 mln (2010: 18.7 mln). 1.5 mln of the growth is as a result of the introduction of new production capacities in the new egg production complex Avis.

 

As previously announced, the Company's average price of shell eggs increased by 12.3% year-on-year to UAH 0.645/ US$0.086 (2010: UAH 0.577/ US$ 0.078). The average price growth in 2011 was connected with the significant increase in export volumes, particularly in Q4 2011, and the reallocation of distribution channels focused on modern sales channels (supermarkets).

 

The production of dry egg product increased by 19.6% year-on-year to 12.2 thou tons (2010: 10.2 thou tons), following a strong growth in demand in both domestic and export markets. The average selling price for dry egg products declined by 1.9% year-on-year to US$8.05 (2010: US$ 8.21) following a shift in sales mix and the lower volume of high-end products, including albumin.

 

In 2011, the Company exported approximately 1.1 bln shell eggs and dry egg products in egg equivalent. Key shell eggs and dry egg products export markets in 2011 were the Middle East - 10% and the Far East - 8.3%.

 

The Company's 2011 gross profit increased by 41.9% year-on-year reflecting strong sales volume growth and additional profit received from by-segments. Gross profit margin increased to 40.4%, compared to 35.9% in the previous year, due to rigorous control over the costs of sales.

 

General administrative expenses increased 83.6% year-on-year to US$13.2 mln (2010: US$7.2 mln) as a result of increased employment costs following expansion of the workforce and an increase in the minimum wage and the consequent increase in the services provided by third parties.

 

Distribution expenses increased by 98.4% year-on-year to US$10.0 mln (2010: US$ 5.1 mln), due to salary increases and transportation expenses growth following the diversification of the distribution channels and the increase in supermarket sales.

 

EBITDA grew 27% year-on-year to US$245.8 mln (2010: US$193.5 mln), EBITDA margin stood at 44% (2010: 44%).

 

Operating profit was up 28% year-on-year with operating profit margin increasing slightly from 41.1% to 41.8%.

 

In 2011 there were no changes in Ukrainian legislation regarding agricultural enterprises and government support, but the Company's income from state subsidiaries has decreased significantly year-on-year to US$0.3 mln (2010: US$17.5 mln) due to the absence of loans in the Company's portfolio, the interest on which is compensatory.

 

Net profit for the year increased 6.2% year-on-year to US$196.3 mln (2010: US$184.8 mln) with profit margin of 35.5%.

 

 

5 Excl. VAT

6 Average exchange rate in 2011: 1 US$ = UAH 7.9677; 2010: 1 US$ = UAH 7.9353

7 Excl. VAT

8 Average exchange rate in 2011: 1 US$ = UAH 7.9677; 2010: 1 US$ = UAH 7.9353

 

 

Financial Review

 

In 2011 the Company had net cash generated from operating activities of US$185.7 mln (2010: net cash used in operating activities - US$159 mln). This is a result of no significant fluctuations in the working capital, namely in stocks, trade payables and advances received if compared to 2010.

 

Net cash used in investing activities was US$161.6 mln in 2011, (2010: net cash generated from investing activities - US$147.5 mln) in line with the Company's investment programme.

 

Net cash generated from financing activities was US$31.7 mln in 2011 (2010: US$192.6 mln). The Company received US$95 mln of new loans and repaid US$38.1 mln, as well as repaying US$25.2 mln of interest on outstanding bonds.

 

The Company's cash balance stood at US$230.6 mln at the end of 2011 (95% of it was denominated in US$) (2010: US$183.1 mln). The Company's net debt amounted to US$80.3 mln at the end of 2011 (2010: US$77.7 mln).

 

 

Other information

 

In 2011 LLC Imperovo Ltd which owns property, plant and equipment of the Company's egg processing plant LLC Imperovo Foods was integrated into the Group.

 

 

# # #

There will be a conference call for analysts and investors today at 10.00 US Eastern time/14.00 UK time, 16.00 Kiev time and 18.00 Moscow time.

 

International number:

+44 (0)20 7162 0025

Russian toll free number:

81 0800 2806 3011

ID:

Avangard

 

A live webcast of the presentation will be available at

http://wcc.webeventservices.com/r.htm?e=440167&s=1&k=57C796B9D8BA83BF03043FA424C149F4&cb=blank

 

Please register approximately 15 minutes prior to the start of the call.

 

 

Additional information:

 

FTI London

Larisa Millings

Sophie Moate

 

+44 20 7831 3113

FTI Moscow

Oleg Leonov

 

 

+7 495 795 06 23

 

For investor relations enquiries:

 

Victoria Korolchuk

AVANGARDCO IPL

Head of Investor Relations

 

phone.: +38 044 593 28 60

mob.: +38 067 214 84 23

e-mail: v.korolchuk@avangardco.ua

 

 

Information for editors

 

Avangardco IPL is one of the largest agro-industrial companies in Ukraine, specializing in the production of eggs and egg products. Based on figures for the year 2011, the Company holds a 32% share of the Ukrainian egg market (51% of the industrial egg market) and a 87% share of the Ukrainian egg products market. As of 31 December 2011, the total poultry stock of the Company was 25.1 million heads. The Company's plants are located in 14 regions of Ukraine and the Autonomous Republic of Crimea. In 2011 the Company exported its products to the Middle East and Asia. In 2011, revenues amounted to US$553.3 mln (2010: US$439.7 mln) and EBITDA was $245.8 mln (2010: US$193.5 mln).

 

The Company's shares, in the form of Global Depositary Receipts, have been traded on the London Stock Exchange since May 2010. Eurobonds of around $200 mln with a maturity on 29 October 2015 were included in the official list of the UK Listing Authority (UKLA) and admitted to trading on a regulated market of the London Stock Exchange since November 1, 2010.

 

 

 

Consolidated statement of financial position

AS AT 31 DECEMBER 2011

(in US$ thousands, unless otherwise stated)

 

31 December 2011

31 December 2010

ASSETS

Property, plant and equipment

512.697

396.236

Held-to-maturity financial assets

-

295

Non-current biological assets

44.304

59.078

Deferred tax assets

1.922

-

Other non-current assets

93.041

60.428

Non-current assets

651.964

516.037

Inventories

202.279

185.624

Current biological assets

58.916

44.705

Trade accounts receivable, net

51.437

54.678

Prepaid income tax

-

7

Prepayments and other current assets, net

26.946

41.829

Taxes recoverable and prepaid, net

76.298

53.084

Cash and cash equivalents

237.814

183.065

Total current assets

653.690

562.992

TOTAL ASSETS

1.305.654

1.079.029

EQUITY

Share capital

836

836

Share premium

201.164

201.164

Reserve capital

115.858

115.858

Retained earnings

673.909

482.328

Effect of translation into presentation currency

(67.761)

(64.587)

Equity attributable to owners of the Company

924.006

735.599

Non-controlling interest

15.333

10.620

Total equity

939.339

746.219

LIABILITIES

Long-term loans

15.384

30.999

Long-term bond liabilities

194.563

193.471

Deferred tax liabilities

86

1.110

Deferred income (non-current portion)

5.351

5.676

Long-term finance lease

3.830

6.372

Total non-current liabilities

219.214

237.628

Short-term bond liabilities

25.013

25.120

Current portion of non-current liabilities

26.565

4.319

Short-term loans

53.063

1.036

Trade payables

17.894

23.191

Current income tax liabilities

-

6

Accrued expenses

1.601

1.308

Other current liabilities and accrued expenses

22.965

40.202

Total current liabilities

147.101

95.182

TOTAL LIABILITIES

366.315

332.810

TOTAL EQUITY AND LIABILITIES

1.305.654

1.079.029

 

 

 

Consolidated statement of comprehensive income

FOR THE YEAR ENDED 31 DECEMBER 2011

(in US$ thousands, unless otherwise stated)

 

31 December 2011

31 December 2010

Revenue

553.310

439.703

Profit on revaluation of biological assets at fair

value

23.697

26.187

Cost of sales

(353.232)

(308.144)

GROSS PROFIT

223 775

157.746

General administrative expenses

(13.161)

(7.168)

Distribution expenses

(10.035)

(5.058)

Income from government grants and incentives

318

17.504

Income from special VAT treatment

38.037

21.910

Other operating income and expenses

(7.430)

(4.032)

OPERATING PROFIT

231.504

180.902

Finance income

1.492

34.058

Finance cost

(33.106)

(29.948)

Income from the purchase of subsidiary

191

-

PROFIT BEFORE TAX

200.081

185.012

Income tax expense

(3.787)

(254)

PROFIT FOR THE YEAR

196.294

184 758

OTHER COMPREHENSIVE INCOME FOR

  THE YEAR:

Effect of translation into presentation currency

(3.174)

(450)

TOTAL COMPREHENSIVE INCOME FOR THE

YEAR

 

193.120

 

184.308

PROFIT FOR THE YEAR ATTRIBUTABLE TO:

Owners of the Company

191.943

182.221

Non-controlling interests

4.351

2.537

196.294

184.758

 

Owners of the Company

189.424

181.771

Non-controlling interests

3.696

2.537

193.120

184.308

Earnings per share USS

30

32

(basic and diluted)

 

 

Consolidated statement of cash flows

FOR THE YEAR ENDED 31 DECEMBER 2011

(in US$ thousands, unless otherwise stated)

 

2011

2010

Cash flows from operating activities

Profit before tax

200.081

185.012

Adjustments for:

Depreciation of property, plant and equipment

14.330

12.637

Change in allowance for irrecoverable amounts

814

433

Other provisions

293

30

Loss on disposal of property, plant and equipment

233

56

Impairment of current assets

1.129

259

Effect of fair value adjustments on biological assets

(23.697)

(26.187)

Profit on payables written-off

(26)

(869)

Amortization of deferred income on government

grants

 

(306)

 

306

Loss from disposal of held to maturity investments  

32

-

Discount on long-term bonds amortization

1.092

-

Bargain purchase

(191)

-

Interest income

(1.492)

(34.058)

Interest payable

30.849

25.799

Operating profit before working capital changes

223.141

163.418

Decrease/(increase) in trade receivables

3.282

(7.200)

Decrease/(increase) in prepayments and other current

  assets

 

14.061

 

(23.208)

Increase in taxes recoverable and prepaid

(20.291)

(24.376)

Increase in inventories

(17.120)

(93.127)

Decrease in deferred income

(20)

(593)

Decrease in trade payables

(5.297)

(44.828)

Decrease/(increase) in biological assets

23.401

(11.140)

Decrease in finance leases

(802)

-

Decrease in advances received and other current

liabilities and accrued expenses

 

(15.456)

 

(94.344)

Cash generated from/(used in) operations

204.899

(135.399)

Interest paid

(12.256)

(23.526)

Income tax paid

(6.782)

(34)

Net cash generated from/(used in) operating

  activities

 

185.661

 

(158.959)

Cash flows from investing activities:

Payments and receipts - property, plant and equipment

(113.021)

(82.157)

Payments for prepayments of property, plant and

equipment

 

(32.613)

 

(1)

Decrease in bank deposits

-

156.421

Proceeds from disposal of held to maturity

investments

 

225

 

-

Payment of acquisition of held to maturity investments

-

(255)

Payment of acquisitions of subsidiary

(17.722)

-

Interest received

1.502

73.459

Net cash (used in)/generated from investing

  activities

 

(161.629)

 

147.468

 

 

 

Consolidated statement of cash flows (cont.)

FOR THE YEAR ENDED 31 DECEMBER 2011

(in US$ thousands, unless otherwise stated)

 

2011

2010

Cash flows from financing activities

New loans received

94.976

166.646

Repayment of loans

(38.056)

(364.351)

Interest paid for bonds issued

(25.183)

(4.267)

Proceeds from long-term bonds issued

-

193.471

Repayment of short-term bonds issued

(19)

Increase in share capital - share issue (nominal value)

-

192

Increase in share capital - share premium

-

201.164

Net cash generated from financing activities

31.718

192.855

Effect from translation to presentation currency

(1.201)

-

Net increase in cash and cash equivalents

54.749

181.364

Restricted cash

(7.174)

-

Cash and cash equivalents at the beginning of the year

183.065

1.701

Cash and cash equivalents at the end of the year

230.640

183.065

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FMGZFFGFGZZZ
Date   Source Headline
3rd Dec 20214:40 pmRNSSecond Price Monitoring Extn
3rd Dec 20214:35 pmRNSPrice Monitoring Extension
18th Dec 202011:57 amRNSResult of AGM
20th Nov 20202:29 pmRNSNotice of AGM
4th Sep 202012:07 pmRNSSecond Price Monitoring Extn
4th Sep 202012:02 pmRNSPrice Monitoring Extension
8th Nov 20194:41 pmRNSSecond Price Monitoring Extn
8th Nov 20194:35 pmRNSPrice Monitoring Extension
8th Nov 201912:02 pmRNSPrice Monitoring Extension
18th Oct 20197:18 amRNSResult of AGM
20th Sep 20198:05 amRNSNotice of AGM
30th Aug 20197:00 amRNSHalf-year Report
26th Apr 20197:00 amRNSAnnual Financial Report
5th Apr 20197:00 amRNSFinal Results
6th Feb 20194:55 pmRNSDEBT RESTRUCTURING AGREEMENT WITH OSCHADBANK
29th Oct 20184:34 pmRNSPostponement Of Principal Redemption
26th Sep 201810:23 amRNSResults of AGM
31st Aug 201812:24 pmRNSAGM Notification
31st May 20187:00 amRNS1st Quarter Results
2nd May 20182:25 pmRNSAvangardco May 2018 Interest Payment
26th Apr 20187:00 amRNS2017 Annual Report Publication
29th Mar 20187:00 amRNSFinal Results
20th Feb 20189:52 amRNSEU APPROVAL TO EXPORT SHELL EGGS
30th Nov 20177:00 amRNS3rd Quarter Results
30th Oct 20179:08 amRNSOCTOBER 2017 INTEREST PAYMENT
9th Oct 20172:11 pmRNSResult of AGM
28th Sep 20171:02 pmRNSULF SEPTEMBER 2017 INTEREST PAYMENT
13th Sep 20172:51 pmRNSNotice of AGM
31st Aug 20177:00 amRNSHalf-year Report
17th Jul 201710:07 amRNSFinancial Advisor Appointment
31st May 20177:00 amRNS1st Quarter Results
2nd May 20172:07 pmRNSApril 2017 Interest Payment
26th Apr 20179:55 amRNSAnnual Financial Report
6th Apr 20173:45 pmRNSSecond Price Monitoring Extn
6th Apr 20173:40 pmRNSPrice Monitoring Extension
29th Mar 20177:00 amRNSFinal Results
22nd Mar 20171:43 pmRNSNotice of Results
21st Mar 20179:30 amRNSUKRLANDFARMING PLC MARCH 2017 INTEREST PAYMENT
17th Mar 20176:02 pmRNSCORRECTION: Comment on temporary ban on import
17th Mar 201710:25 amRNSComment on temporary ban on import from Ukraine
20th Dec 20163:45 pmRNSSecond Price Monitoring Extn
20th Dec 20163:40 pmRNSPrice Monitoring Extension
30th Nov 20167:00 amRNS3rd Quarter Results
25th Nov 201612:23 pmRNSNotice of Results
26th Sep 20163:45 pmRNSSecond Price Monitoring Extn
26th Sep 20163:40 pmRNSPrice Monitoring Extension
16th Sep 20162:19 pmRNSResults of AGM
6th Sep 20163:45 pmRNSSecond Price Monitoring Extn
6th Sep 20163:40 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.